122
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Elucidating Pathways Mediating the Relationship Between Male Sex and COVID-19 Severity

, , , , , & ORCID Icon show all
Pages 115-125 | Published online: 25 Jan 2022

References

  • Peckham H, de Gruijter NM, Raine C, et al. Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission. Nat Commun. 2020;11(1):1–10. doi:10.1038/s41467-020-19741-6
  • Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–513. doi:10.1016/S0140-6736(20)30211-7
  • Epidemiology Working Group for NCIP Epidemic Response, Chinese Center for Disease Control and Prevention. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Zhonghua Liu Xing Bing Xue Za Zhi. 2020;41(2):145. doi:10.3760/cma.j.issn.0254-6450.2020.02.003
  • Jin J-M, Bai P, He W, et al. Gender differences in patients with COVID-19: focus on severity and mortality. Front Public health. 2020;8:152. doi:10.3389/fpubh.2020.00152
  • Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. New Engl J Med. 2020;382(18):1708–1720. doi:10.1056/NEJMoa2002032
  • Mo P, Xing Y, Xiao Y, et al. Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China. Clin Infect Dis. 2020;73:11.
  • The COVID-19 sex-disaggregated data tracker; 2021. Available from: https://globalhealth5050.org/the-sex-gender-and-covid-19-project/dataset/. Accessed January 6, 2022.
  • Conti P, Younes A. Coronavirus COV-19/SARS-CoV-2 affects women less than men: clinical response to viral infection. J Biol Regul Homeost Agents. 2020;34(2):339–343. doi:10.23812/Editorial-Conti-3
  • Gebhard C, Regitz-Zagrosek V, Neuhauser HK, Morgan R, Klein SL. Impact of sex and gender on COVID-19 outcomes in Europe. Biol Sex Differ. 2020;11:1–13. doi:10.1186/s13293-020-00304-9
  • Wenham C, Smith J, Morgan R. COVID-19: the gendered impacts of the outbreak. Lancet. 2020;395(10227):846–848. doi:10.1016/S0140-6736(20)30526-2
  • Lieberman NA, Peddu V, Xie H, et al. In vivo antiviral host transcriptional response to SARS-CoV-2 by viral load, sex, and age. PLoS Biol. 2020;18(9):e3000849. doi:10.1371/journal.pbio.3000849
  • Takahashi T, Ellingson MK, Wong P, et al. Sex differences in immune responses that underlie COVID-19 disease outcomes. Nature. 2020;588(7837):315–320. doi:10.1038/s41586-020-2700-3
  • Marshall JC, Murthy S, Diaz J, et al. A minimal common outcome measure set for COVID-19 clinical research. Lancet Infect Dis. 2020;20(8):e192–e197. doi:10.1016/S1473-3099(20)30483-7
  • Kind AJ, Buckingham WR. Making neighborhood-disadvantage metrics accessible—the neighborhood atlas. N Engl J Med. 2018;378(26):2456. doi:10.1056/NEJMp1802313
  • Area deprivation index, 2018 version; 2020. Available from: https://www.neighborhoodatlas.medicine.wisc.edu/. Accessed July 29, 2020.
  • Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383. doi:10.1016/0021-9681(87)90171-8
  • UW laboratory test guide; 2021. Available from: https://testguide.labmed.uw.edu/public/. Accessed February 2, 2021.
  • Scully EP, Schumock G, Fu M, et al. Sex and gender differences in testing, hospital admission, clinical presentation, and drivers of severe outcomes from COVID-19. Open Forum Infect Dis. 2021;8(9):ofab448. doi:10.1093/ofid/ofab448
  • Meng Y, Wu P, Lu W, et al. Sex-specific clinical characteristics and prognosis of coronavirus disease-19 infection in Wuhan, China: a retrospective study of 168 severe patients. PLoS Pathog. 2020;16(4):e1008520. doi:10.1371/journal.ppat.1008520
  • Qin L, Li X, Shi J, et al. Gendered effects on inflammation reaction and outcome of COVID‐19 patients in Wuhan. J Med Virol. 2020;92(11):2684–2692. doi:10.1002/jmv.26137
  • Zeng F, Dai C, Cai P, et al. A comparison study of SARS‐CoV‐2 IgG antibody between male and female COVID‐19 patients: a possible reason underlying different outcome between sex. J Med Virol. 2020;92(10):2050–2054. doi:10.1002/jmv.25989
  • Asselta R, Paraboschi EM, Mantovani A, Duga S. ACE2 and TMPRSS2 variants and expression as candidates to sex and country differences in COVID-19 severity in Italy. 2020;12:10087.
  • Dana PM, Sadoughi F, Hallajzadeh J, et al. An insight into the sex differences in COVID-19 patients: what are the possible causes? Prehosp Disaster Med. 2020;35(4):438–441. doi:10.1017/S1049023X20000837
  • Lazartigues E, Qadir MMF, Mauvais-Jarvis F. Endocrine significance of SARS-CoV-2ʹs reliance on ACE2. Endocrinology. 2020;161(9):bqaa108. doi:10.1210/endocr/bqaa108
  • Li Y, Jerkic M, Slutsky AS, Zhang H. Molecular mechanisms of sex bias differences in COVID-19 mortality. Critical Care. 2020;24(1):1–6. doi:10.1186/s13054-020-03118-8
  • Ngo ST, Steyn FJ, McCombe PA. Gender differences in autoimmune disease. Front Neuroendocrinol. 2014;35(3):347–369. doi:10.1016/j.yfrne.2014.04.004
  • Gee J, Marquez P, Su J. First month of COVID-19 vaccine safety monitoring—United States, December 14, 2020–January 13, 2021. MMWR Morb Mortal Wkly Rep. 2021;70:283–288. doi:10.15585/mmwr.mm7008e3
  • Shimabukuro T, Cole M, Su J. Reports of Anaphylaxis After Receipt of mRNA COVID-19—United States, December 14, 2020–January 18, 2021. JAMA. 2021;325(11):1101. doi:10.1001/jama.2021.1967
  • Palaiodimos L, Kokkinidis DG, Li W, et al. Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York. Metabolism. 2020;108:154262. doi:10.1016/j.metabol.2020.154262